New drug discounts should be made transparent

February 8, 2012
Medical Communications, Sales and Marketing ABPI, NHS, NICE, access scheme, pricing

Patient access schemes agreed through NICE should be made more transparent.  This is according to Paul McManus, a pharmacist and …

GSK picture

GSK posts strong underlying sales growth

February 8, 2012
Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …

Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Merck prepares insomnia candidate

February 7, 2012
Sales and Marketing Merck, insomnia

Merck is to file its new insomnia drug suvorexant, with US regulators later this year. Suvorexant is an orexin receptor …

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …

Roche rounds off year with solid performance

February 3, 2012
Sales and Marketing Roche

A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results …

Andrew Morgan joins Republic M!

February 2, 2012
Business Services, Medical Communications, Sales and Marketing Andrew Morgan, Republic M!

Republic M! has strengthened its team with the appointment of Andrew Morgan as head of operations. Andrew has leadership expertise …

Merck image

Merck posts strong results for 2011

February 2, 2012
Sales and Marketing Frazier, Merck, Singulair, Victrelis

Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011.  The US firm …

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …

AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

The Gateway to Local Adoption Series

Latest content